A Study to Evaluate the Safety and Efficacy of ASP015K in Moderate to Severe Rheumatoid Arthritis Subjects Who Have Had an Inadequate Response to Methotrexate
Clinical trial NCT01554696 · COMPLETED
Trial details
- NCT number
- NCT01554696
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-07-06
- Primary completion
- 2014-02-11
- Enrollment
- 379
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.